Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07009691 · ClinicalTrials.gov registry record · NA
Hydrogen Water Intervention With Heart Rate Variability as an Outcome Biomarker in ME/CFS
A NA study of Chronic Fatigue Syndrome, sponsored by Stony Brook University.
- Recruiting
- Registry status
- NA
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT07009691: Recruiting NA study of Chronic Fatigue Syndrome, sponsored by Stony Brook University.
NCT07009691 is a NA study of Chronic Fatigue Syndrome that is actively recruiting participants, run by Stony Brook University. The registered enrollment target is 50 participants, below the 7,244-participant average among 14 other Chronic Fatigue Syndrome trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07009691, a NA study of Chronic Fatigue Syndrome, is actively recruiting participants, sponsored by Stony Brook University.
- RECRUITING
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical trial is to learn if the OTC supplement, hydrogen water, works to treat the fatigue-related symptoms and functional limitations in adults with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). It will also examine if heart rate variability (HRV) can be used to predict who will benefit from the hydrogen water treatment. The main questions it aims to answer are: Does the OTC supplement, hydrogen water, work to reduce the fatigue-related symptoms and improve functioning in participants who have ME/CFS? Can HRV be used to predict who will benefit from treatment with hydrogen water?
Primary Outcome
This is a validated self-report measure of the effect of fatigue on functioning.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Hydrogen water which is prepared from an OTC supplement.
Study Locations (1)
New York
- Stony Brook University - Stony Brook
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2025-06-09 |
| Est. Completion | 2026-05-31 |
| Phase | NA |
What NCT07009691 shows while recruiting
NCT07009691 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 7,244-participant average among 14 other Chronic Fatigue Syndrome trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Chronic Fatigue Syndrome appearing as the primary indexed condition, and to 1 intervention - of which Hydrogen water which is prepared from an OTC supplement. is the first listed.
NCT07009691 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT07009691 about?
NCT07009691 is a clinical study titled "Hydrogen Water Intervention With Heart Rate Variability as an Outcome Biomarker in ME/CFS". The goal of this clinical trial is to learn if the OTC supplement, hydrogen water, works to treat the fatigue-related symptoms and functional limitations in adults with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). It will also examine if heart rate variability (HRV) can be used to pr...
What is the current status of trial NCT07009691?
This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2025-06-09. Estimated completion is 2026-05-31.
What conditions does trial NCT07009691 study?
This clinical trial studies the following conditions: Chronic Fatigue Syndrome.
What interventions are being tested in trial NCT07009691?
The interventions under investigation include: Hydrogen water which is prepared from an OTC supplement. (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT07009691?
This trial is sponsored by Stony Brook University, which has 127 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07009691 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Fatigue Syndrome
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07009691's enrollment target sits among peer trials
50 8th of 14 higher than 6 of 14 other Chronic Fatigue Syndrome trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Chronic Fatigue Syndrome trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
tVNS in Long COVID-19
RECRUITING · NA
-
The Long COVID-19 Wearable Device Study
RECRUITING · NA
-
Does a Technology Enabled Multi-disciplinary Team-based Care Model for the Management of Long COVID and Other Fatiguing Illnesses Improve Clinical Care of Patients and Represent a Sustainable Approach Within a Federally Qualified Health Center?
ACTIVE NOT RECRUITING · NA
-
Hyporeactivity and Gulf War Illness
COMPLETED · NA
-
Cardiovascular Analysis of PEM
COMPLETED · NA
-
Acupressure for Pain Management and Fatigue Relief in Gulf War Veterans
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI